2,2-Bis(4-carboxyphenyl)hexafluoropropane, 98.0%, 1g

6-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

Trial kit Spectra/Por® Biotech CE, 500–1000 dalton(s), 1 Piece(s)

methyl 3-(piperazin-1-yl)propanoate dihydrochloride, 95.0%, 10g

(R)-2-((tert-Butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetic acid, 97%, 25g

(4-(N-(TERT-BUTYL)SULFAMOYL)-3-FLUOROPHENYL)BORONIC ACID, 95%, 250mg

1,2-DIHYDRO-2,6-NAPHTHYRIDIN-3(4H)-ONE, 95.0%, 1g

ETHYL 3-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXYLATE, 95.0%, 250mg

2-Amino-4,5-dichlorobenzonitrile, 97%, 1g

1-(3-METHYLOXETAN-3-YL)PIPERAZINE, 95.0%, 250mg

6-Aminobenzo[b]thiophene 1,1-dioxide, 95.0%, 5g

(4-Bromo-2-fluorophenyl)(3,3-dimethylazetidin-1-yl)methanone, 98+%, 100mg

6-Bromo-1,2,3,4-tetrahydro-1,8-naphthyridine, 95.0%, 250mg